<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658362"><TermName>recombinant urate oxidase</TermName><TermPronunciation>(ree-KOM-bih-nunt YOOR-ayt OK-sih-days)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat high blood levels of uric acid in patients with leukemia, lymphoma, and other types of cancer who are receiving certain types of cancer treatment. It is also being studied in the treatment of other medical conditions.  Recombinant urate oxidase is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and rasburicase.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725916" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;recombinant urate oxidase&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725917" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;urato oxidasa recombinante&quot;" language="es" id="_4"/><SpanishTermName>urato oxidasa recombinante</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar concentraciones altas de ácido úrico en pacientes con leucemia, linfoma y otros tipos de cáncer que se encuentran bajo ciertos tratamientos. También está en estudio para el tratamiento de otras afecciones médicas.  El urato de oxidasa recombinante es un tipo de  enzima recombinante y un tipo de medicamento que disminuye el urato. También se llama Elitex y rasburicase.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-11-10</DateFirstPublished><DateLastModified>2009-11-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000658556">Rasburicase</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
